Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,786
archived clinical trials in
Dermatology

Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
University of Washington Medical Center
2
mi
from 98109
Seattle, WA
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
University of Washington Medical Center
2
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Cancer Care Northwest - Spokane South
229
mi
from 98109
Spokane, WA
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Cancer Care Northwest - Spokane South
229
mi
from 98109
Spokane, WA
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Evergreen Hematology and Oncology, PS
229
mi
from 98109
Spokane, WA
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Evergreen Hematology and Oncology, PS
229
mi
from 98109
Spokane, WA
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Wenatchee Valley Hospital and Clinics
95
mi
from 98109
Wenatchee, WA
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Wenatchee Valley Hospital and Clinics
95
mi
from 98109
Wenatchee, WA
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Rocky Mountain Oncology
846
mi
from 98109
Casper, WY
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Rocky Mountain Oncology
846
mi
from 98109
Casper, WY
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Welch Cancer Center
759
mi
from 98109
Sheridan, WY
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Welch Cancer Center
759
mi
from 98109
Sheridan, WY
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Mercy Hospital Fort Smith
1664
mi
from 98109
Fort Smith, AR
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Mercy Hospital Fort Smith
1664
mi
from 98109
Fort Smith, AR
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Cotton O'Neil Cancer Center / Stormont Vail Health
1454
mi
from 98109
Topeka, KA
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Cotton O'Neil Cancer Center / Stormont Vail Health
1454
mi
from 98109
Topeka, KA
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Saint Vincent Frontier Cancer Center
667
mi
from 98109
Billings, MT
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Saint Vincent Frontier Cancer Center
667
mi
from 98109
Billings, MT
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente Washington
22
mi
from 98109
Seattle, WA
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente Washington
22
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Shawnee Mission Medical Center-KCCC
1500
mi
from 98109
Shawnee Mission, KA
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Shawnee Mission Medical Center-KCCC
1500
mi
from 98109
Shawnee Mission, KA
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Providence Hospital,
2147
mi
from 98109
Mobile, AL
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Providence Hospital,
2147
mi
from 98109
Mobile, AL
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Highlands Oncology Group-Rogers
1632
mi
from 98109
Rogers, AR
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Highlands Oncology Group-Rogers
1632
mi
from 98109
Rogers, AR
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
UF Cancer Center at Orlando Health
2549
mi
from 98109
Orlando, FL
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
UF Cancer Center at Orlando Health
2549
mi
from 98109
Orlando, FL
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
1467
mi
from 98109
Savannah, GA
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
1467
mi
from 98109
Savannah, GA
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Southwest Medical Center
1307
mi
from 98109
Liberal, KA
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Southwest Medical Center
1307
mi
from 98109
Liberal, KA
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Benefis Healthcare- Sletten Cancer Institute
514
mi
from 98109
Great Falls, MT
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Benefis Healthcare- Sletten Cancer Institute
514
mi
from 98109
Great Falls, MT
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
University Medical Center of Southern Nevada
873
mi
from 98109
Las Vegas, NV
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
University Medical Center of Southern Nevada
873
mi
from 98109
Las Vegas, NV
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
University of Rochester
2161
mi
from 98109
Rochester, NY
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
University of Rochester
2161
mi
from 98109
Rochester, NY
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Novant Health Presbyterian Medical Center
2282
mi
from 98109
Charlotte, NC
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Novant Health Presbyterian Medical Center
2282
mi
from 98109
Charlotte, NC
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Wayne Memorial Hospital
2407
mi
from 98109
Goldsboro, NC
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Wayne Memorial Hospital
2407
mi
from 98109
Goldsboro, NC
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Providence Milwaukie Hospital
151
mi
from 98109
Milwaukie, OR
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Providence Milwaukie Hospital
151
mi
from 98109
Milwaukie, OR
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Providence Portland Medical Center
147
mi
from 98109
Portland, OR
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Providence Portland Medical Center
147
mi
from 98109
Portland, OR
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Providence Saint Vincent Medical Center
148
mi
from 98109
Portland, OR
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Providence Saint Vincent Medical Center
148
mi
from 98109
Portland, OR
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Salem Hospital
189
mi
from 98109
Salem, OR
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Salem Hospital
189
mi
from 98109
Salem, OR
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Saint Francis Hospital
2224
mi
from 98109
Greenville, SC
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Saint Francis Hospital
2224
mi
from 98109
Greenville, SC
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Wellmont Holston Valley Hospital and Medical Center
2150
mi
from 98109
Kingsport, TN
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Wellmont Holston Valley Hospital and Medical Center
2150
mi
from 98109
Kingsport, TN
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Thompson Cancer Survival Center
2110
mi
from 98109
Knoxville, TN
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Thompson Cancer Survival Center
2110
mi
from 98109
Knoxville, TN
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Southwest VA Regional Cancer Center
2133
mi
from 98109
Norton, VA
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Southwest VA Regional Cancer Center
2133
mi
from 98109
Norton, VA
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
PeaceHealth Southwest Medical Center
mi
from 98109
Vancouver, WA
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
PeaceHealth Southwest Medical Center
mi
from 98109
Vancouver, WA
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Memorial Health University Medical Center
2403
mi
from 98109
Savannah, GA
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Memorial Health University Medical Center
2403
mi
from 98109
Savannah, GA
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
AMG Oncology - Naperville
1712
mi
from 98109
Naperville, IL
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
AMG Oncology - Naperville
1712
mi
from 98109
Naperville, IL
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
FirstHealth of the Carolinas-Moore Regional Hospital
2346
mi
from 98109
Pinehurst, NC
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
FirstHealth of the Carolinas-Moore Regional Hospital
2346
mi
from 98109
Pinehurst, NC
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Sovah Health Martinsville
2269
mi
from 98109
Martinsville, VA
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Sovah Health Martinsville
2269
mi
from 98109
Martinsville, VA
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Cancer Care Specialists of Illinois - Decatur
1734
mi
from 98109
Decatur, IL
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Cancer Care Specialists of Illinois - Decatur
1734
mi
from 98109
Decatur, IL
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Ascension Saint John Hospital
1933
mi
from 98109
Detroit, MI
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Ascension Saint John Hospital
1933
mi
from 98109
Detroit, MI
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Miami Valley Hospital North
1959
mi
from 98109
Dayton, OH
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Miami Valley Hospital North
1959
mi
from 98109
Dayton, OH
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Ascension Saint Mary's Hospital
1861
mi
from 98109
Saginaw, MI
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Ascension Saint Mary's Hospital
1861
mi
from 98109
Saginaw, MI
Click here to add this to my saved trials
Impact of Narrowband UVB Phototherapy on Systemic Inflammation in Patients With Atopic Dermatitis
Impact of Narrowband UVB Phototherapy on Systemic Inflammation in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Rockefeller University
2401
mi
from 98109
New York, NY
Impact of Narrowband UVB Phototherapy on Systemic Inflammation in Patients With Atopic Dermatitis
Impact of Narrowband UVB Phototherapy on Systemic Inflammation in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Rockefeller University
2401
mi
from 98109
New York, NY
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Burke Pharmaceutical Research
1759
mi
from 98109
Hot Springs, AR
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Burke Pharmaceutical Research
1759
mi
from 98109
Hot Springs, AR
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Center for Dermatology Clinical Research
698
mi
from 98109
Fremont, CA
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Center for Dermatology Clinical Research
698
mi
from 98109
Fremont, CA
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Dermatology Specialists, Inc
1008
mi
from 98109
Murrieta, CA
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Dermatology Specialists, Inc
1008
mi
from 98109
Murrieta, CA
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Dermatology Specialists, Inc.
1031
mi
from 98109
Oceanside, CA
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Dermatology Specialists, Inc.
1031
mi
from 98109
Oceanside, CA
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Contour Dermatology & Cosmetic Surgery Center
1008
mi
from 98109
Rancho Mirage, CA
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Contour Dermatology & Cosmetic Surgery Center
1008
mi
from 98109
Rancho Mirage, CA
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Skin Surgery Medical Group, Inc.
1057
mi
from 98109
San Diego, CA
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Skin Surgery Medical Group, Inc.
1057
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Therapeutics Clinical Research
1060
mi
from 98109
San Diego, CA
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Therapeutics Clinical Research
1060
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
University Clinical Trials, Inc.
1065
mi
from 98109
San Diego, CA
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
University Clinical Trials, Inc.
1065
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Southern California Dermatology, Inc.
987
mi
from 98109
Santa Ana, CA
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Southern California Dermatology, Inc.
987
mi
from 98109
Santa Ana, CA
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Colorado Medical Research Center
1024
mi
from 98109
Denver, CO
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Colorado Medical Research Center
1024
mi
from 98109
Denver, CO
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
AboutSkin Dermatology and DermSurgery
1027
mi
from 98109
Greenwood Village, CO
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
AboutSkin Dermatology and DermSurgery
1027
mi
from 98109
Greenwood Village, CO
Click here to add this to my saved trials